Evidence for co-expression and desensitization of A(2a) and A(2b) adenosine receptors in NG108-15 cells

Biochemical Pharmacology

Volumn 55, Issue 5, 1998, Pages 595-603

  Mundell, Stuart J ^a   Kelly, Eamonn ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenosine receptors; Adenylyl cyclase; Desensitization; NG108 15 cells

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3 CHLOROSTYRYL)CAFFEINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENYLATE CYCLASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVITY; GENE EXPRESSION; GLIOMA CELL; HYBRID CELL; IN VITRO STUDY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADENYLATE CYCLASE; ENZYME ACTIVATION; GLIOMA; HYBRID CELLS; NEUROBLASTOMA; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1; TUMOR CELLS, CULTURED;

EID: 0032032198     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00466-8     Document Type: Article

References (34)

1. 1. Fredholm BB, Abbracchio MP, Burnstock G, Daly W, Harden TK, Jacobson KA, Leff P and Williams M, Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143-156, 1994.
2. 2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173: 1169-1178, 1990.
3. 3. Stehle JH, Rivkees SA, Lee JJ, Weaver DR, Deeds JD and Reppert SM, Molecular cloning and expression of the cDNA for a novel adenosine receptor subtype. Mol Endocrinol 6: 384-393, 1992.
4. 2b adenosine receptor. Mol Endocrinol 6: 1598-1604, 1992.
5. 2 receptors in rat brain. J Pharmacol Exp Ther 251: 888-893, 1989.
6. 2 adenosine antagonist in vitro and in vivo. FEBS Lett 323: 141-144, 1993.
7. 3H]-NECA in rat striatal membranes. Mol Pharmacol 29: 331-346, 1986.
8. 2b receptor. Mol Pharmacol 47: 1126-1132, 1995.
9. 2 receptor in PC12 cells. Life Sci 39: 1059-1067, 1986.
10. 2b adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylyl cyclase. Mol Pharmacol 41: 352-359, 1992.
11. 2b, adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47: 801-814, 1994.
12. 3H-NECA that is not an adenosine receptor. Biochem Pharmacol 38: 3827-3833, 1989.
13. 13. Kenimer JG and Nirenberg M, Desensitization of adenylate cyclase to prostaglandin E1 or 2-chloroadenosine. Mol Pharmacol 20: 585-591, 1981.
14. 14. Brown BL, Albano JDM, Ekins RP, Sgherzi AM and Tampion W, A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphate. Biochem J 121: 561-562, 1971.
15. 15. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
16. 16. Olah ME and Stiles GL, Adenosine receptor subtypes: characterization and therapeutic regulation. Ann Rev Pharmacol Toxicol 35: 581-606, 1995.
17. 3H]adenosine binding in relation to adenylate cyclase activity. Naunyn-Schmiedebergs Arch Pharmacol 325: 226-233, 1984.
18. 18. Hutchison KA, Nevins B, Perini F and Fox IH, Soluble and membrane-associated human low affinity adenosine binding protein (adenotin): properties and homology with mammalian and avian stress proteins. Biochemistry 29: 5138-5144, 1990.
19. 2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn-Schmiedebergs Arch Pharmacol 353: 250-260, 1996.
20. 2b receptors in cultured fetal chick heart cells. High-and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation. Circ Res 76: 242-251, 1995.
21. 21. Newman ME and Levitzki A, Desensitization of normal rat kidney cells to cdenosine. Biochem Pharmacol 32: 137-140, 1983.
22. 22. Luty J, Hunt JA, Nobbs PK, Kelly E, Keen M and Macdermot J, Expression and desensitization of purinoceptors on cultured bovine aortic endothelial cells. Cardiovascular Res 23: 303-307, 1989.
23. 2 adenosine receptor-adenylate cyclase system in vascular smooth muscle cells from rat aorta. Mol and Cell Endocrinol 62: 273-279, 1989.
24. 24. Chern Y, Lai H, Fong JC and Liang Y, Multiple mechanisms for desensitization of adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol Pharmacol 44: 950-958, 1943.
25. 2a adenosine receptor: delineation of multiple processes. Mol Pharmacol 45: 1082-1094, 1994.
26. 26. Hausdorff WP, Caron MG and Lefkowitz RJ, Turning of the signal: desensitization of β-adrenergic receptor function. FASEB J 4: 2881-2889, 1990.
27. 27. Lohse MJ, Benovic JL, Caron MG and Lefkowitz RJ, Multiple pathways of rapid adrenergic receptor desensitization. J Biol Chem 265: 3202-3209, 1990.
28. 28. Sternemarr R and Benovic JL, Regulation of G-protein-coupled receptors by receptor kinases. Vitam Horm 51: 193-234, 1995.
29. s function. Biochim et Biophys Acta 1134: 157-163, 1992.
30. 2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry 36: 832-838, 1997.
31. 31. Benovic JL, Mayor F Jr., Staniszewski C, Lefkowitz RJ and Caron MG, Purification and characterization of the β-adrenergic receptor kinase. J Biol Chem 262: 9026-9032, 1987.
32. 4 receptor desensitization in colliculi neurons. Mol Pharmacol 42: 808-816, 1992.
33. 33. Kong G, Penn R and Benovic JL, A β-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the adrenergic receptor. J Biol Chem 269: 13084-13087, 1994.
34. 2 receptor desensitization. Mol Pharmacol 51: 991-996, 1997.